A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis

NCT03698448 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Determined not feasible

Conditions

Cystic Fibrosis

Interventions

DRUG: OligoG Dry powder for inhalation

Sponsor

AlgiPharma AS

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]